Catalysts
PRODUCTS
-
At Mikart, our mission is to leverage our technical expertise in pharmaceutical development and manufacturing to deliver services that meet the diverse needs of our customers.
-
Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.
-
Deliver cost-effective, reliable public infrastructure—from permitting and construction to operation, maintenance and replacement. From the office to the field, Trimble Cityworks helps you improve service to your community while increasing safety, efficiency and performance.
-
BioBLU Single-Use Bioreactors combine the advantages of single-use technology with the trusted performance of stirred-tank design. Different variants are suitable for cell culture and microbial fermentation in R&D and clinical and commercial manufacturing. BioBLU Single-Use Bioreactors are compatible Eppendorf bioprocess controllers.
-
Simplify and intensify upstream bioprocessing. The XCell® ATF System, in single-use or stainless steel format, delivers superior cell retention. High impact upstream applications include N-1 perfusion, high productivity harvest, long-term perfusion and seed train intensification.
WHITE PAPERS AND CASE STUDIES
-
End-To-End Inventory Control Supports Biotech's Expanding Portfolio
Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.
-
Manufacturing With A Highly Potent API For An Ophthalmic Indication
Explore how Altasciences safely develops and manufactures HPAPIs in this case study, featuring nano-milled ophthalmic suspension, advanced containment strategies, and integrated solutions.
-
EHR-To-EDC Success In A Complex, Adaptive Platform Trial
I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
Controlling Biofouling In Governador José Richa Power Plant, Brazil
Read about an extensive study that was carried out to evaluate the ability of the HOD UV system to control biofouling in the Governador José Richa Power Plant.
-
Manufacturing Transfers: Delivering 140+ Precision Medical Devices Without Missing A Deadline
Go inside a successful manufacturing transfer of over 140 Class-III silicone medical devices and on-time delivery for a top-30 OEM through expert project management and rigorous validation processes.
-
FSP And IVD Clinical Trials
This study highlights the benefits of ProPharma's FSP services for clinical trials, including scalability, risk reduction, cost savings, and timely delivery.
-
Leveraging High-Pressure Sterile Filtration For Highly Viscous Solutions
This research demonstrates the potential of high-pressure sterile filtration to enhance efficiency, reduce waste, and accelerate the development of innovative therapies.
-
Improving Pre-Clinical Study Efficiency With mRNA-LNP Technology
Uncover how Repair Biotechnologies, in collaboration with Vernal Biosciences, helped to pave the way for the next generation of breakthrough treatments for cholesterol and aging-related diseases.
-
Ergomed's Solutions To The Challenges of Oncology Trials
Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
-
Innovative Multilayer Extrusion Technology Solves Product Redesign Challenges
A multinational medical device company successfully worked to redesign a component used in cardiovascular surgery.
-
Ensuring Supply Through Speed And Transparency
Through speed, transparency, and close collaboration, the pharmaceutical company was able to switch vendors seamlessly, maintaining virtually uninterrupted manufacturing operations.
-
End-To-End Support To Advance Gene Therapies For Rare Retinal Diseases
Learn how expert analytical testing and clinical support helped advance a promising gene therapy for rare retinal diseases from the lab to the clinic on an expedited timeline.
NEWS
-
University Of St. Thomas Offers No-Cost Machining And CNC Optimization Training7/18/2025
The University of St. Thomas is launching a new, no-cost training program to help manufacturing professionals, engineers, and students upskill and gain valuable insights into using computer simulations to optimize CNC machining.
-
Agilitas Energy Expands Into Hydropower With Acquisition Of Two Projects In West Virginia And Maryland6/24/2025
Agilitas Energy, a leading developer and operator of renewable energy and energy storage systems, today announced the acquisition of two late-stage hydropower development projects from Advanced Hydro Solutions.
-
QuasarMD Unveils Advanced Full-Body Light Therapy Mat To Support Aging Wellness7/29/2025
QuasarMD LLC, a leader in light-based wellness technologies, announces the launch of its Full-Body Light Therapy Mat, a clinically validated, non-invasive solution designed to address the evolving wellness needs of aging adults.
-
Anritsu Supports Evaluation Of 5G NR NTN Devices For Satellite-Based Communications7/29/2025
Anritsu Corporation, a global leader in test and measurement solutions, is pleased to announce that its Radio Communication Test Station MT8000A, a measurement solution for 5G devices such as smartphones, now supports evaluation of 5G NR NTN devices for non-terrestrial networks (NTN), which enables communication via satellite.
-
Be Part of Photonics Future: CIOE 2025 Visitor Registration Live Now!4/9/2025
The 26th China International Optoelectronic Exposition (CIOE 2025) is set to take place from September 10–12, 2025, at the Shenzhen World Exhibition & Convention Center, spanning 240,000 square meters of exhibition space.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.